Aydın Türkmen

ORCID: 0000-0003-3664-8469
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Renal Transplantation Outcomes and Treatments
  • Renal Diseases and Glomerulopathies
  • Organ Transplantation Techniques and Outcomes
  • Renal and Vascular Pathologies
  • Organ Donation and Transplantation
  • Polyomavirus and related diseases
  • Dialysis and Renal Disease Management
  • COVID-19 Clinical Research Studies
  • Complement system in diseases
  • Pregnancy and Medication Impact
  • Transplantation: Methods and Outcomes
  • Amyloidosis: Diagnosis, Treatment, Outcomes
  • Pharmacological Effects and Toxicity Studies
  • Cytomegalovirus and herpesvirus research
  • Blood groups and transfusion
  • Chronic Kidney Disease and Diabetes
  • Vasculitis and related conditions
  • Systemic Sclerosis and Related Diseases
  • Viral-associated cancers and disorders
  • Long-Term Effects of COVID-19
  • Electrolyte and hormonal disorders
  • COVID-19 and healthcare impacts
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Neurological Complications and Syndromes
  • SARS-CoV-2 and COVID-19 Research

Istanbul University
2016-2025

Koç University
2020-2023

Turkish Society of Hematology
2023

Istanbul Medipol University
2016

Memorial Hospital of South Bend
2015

Istanbul Memorial Hospital
2013

SSK İhtisas Hastanesi
2008

Renal Association
2007

Southmead Hospital
2007

Hospital de Santa Maria
2007

Debora L. Gisch Michelle Brennan Blue B. Lake Jeannine Basta Mark S. Keller and 95 more Ricardo Melo Ferreira Shreeram Akilesh Reetika Ghag Charles Lu Ying‐Hua Cheng Kimberly S. Collins Samir V. Parikh Brad H. Rovin Lynn W. Robbins Lisa Stout Kimberly Y. Conklin Dinh Diep Bo Zhang Amanda Knoten Daria Barwinska Mahla Asghari Angela R. Sabo Michael J. Ferkowicz Timothy A. Sutton Katherine J. Kelly Ian H. de Boer Sylvia E. Rosas Krzysztof Kiryluk Jeffrey B. Hodgin Fadhl Alakwaa Seth Winfree Nichole Jefferson Aydın Türkmen Joseph P. Gaut Nils Gehlenborg Carrie L. Phillips Tarek M. El‐Achkar Pierre C. Dagher Takashi Hato Kun Zhang Jonathan Himmelfarb Matthias Kretzler Shamim Mollah Blue B. Lake Alexander Morales Isaac E. Stillman Stewart H. Lecker Steve Bogen Ashish Verma Guanghao Yu Insa M. Schmidt Joel Henderson Laurence H. Beck Pranav Yadati Sushrut S. Waikar Afolarin Amodu Shana Maikhor Titlayo Ilori Mia R. Colona Astrid Weins Gearoid M. McMahon Nir Hacohen Anna Greka Jamie L. Marshall Paul Hoover Vidya Sankar Viswanathan Dana C. Crawford Mark P. Aulisio William S. Bush Yijiang Chen Anant Madabhushi Charles M. O’Malley Crystal A. Gadegbeku Dianna Sendrey Emilio D. Poggio John O’Toole John R. Sedor Jonathan J. Taliercio Lakeshia Bush Leal Herlitz Ellen L. Palmer Jane Nguyen Kassandra Spates-Harden Leslie Cooperman Stacey E. Jolly Carissa Vinovskis Andrew S. Bomback Jonathan Barasch Krzysztof Kiryluk Paul S. Appelbaum Vivette D. D’Agati Cecilia Berrouet Karla Mehl Maya Sabatello Ning Shang Olivia Balderes Pietro A. Canetta Satoru Kudose Joana P. Gonçalves Lukasz G. Migas

There is a need to define regions of gene activation or repression that control human kidney cells in states health, injury, and repair understand the molecular pathogenesis disease design therapeutic strategies. Comprehensive integration expression with epigenetic features regulatory elements remains significant challenge. We measure dual single nucleus RNA chromatin accessibility, DNA methylation, H3K27ac, H3K4me1, H3K4me3, H3K27me3 histone modifications decipher landscape regulation...

10.1038/s41467-023-44467-6 article EN cc-by Nature Communications 2024-01-10

Hyperkalemia is a major cause of mortality in the patients who suffer from crush syndrome aftermath earthquakes. The aim this study to investigate frequency and effects hyperkalemia 639 victims catastrophic Marmara earthquake that struck northwestern Turkey, August 1999.Within first week disaster, questionnaires were sent 35 reference hospitals treated victims. Information on serum potassium which was provided 595 out submitted analysis.In admitted within 3 days disaster (n = 401) 5.4 +/-...

10.5414/cnp59326 article EN Clinical Nephrology 2003-05-01

Coronavirus Disease 2019 (COVID-19) is currently a pandemic with mortality rate of 1%-6% in the general population. However, seems to be significantly higher elderly patients, especially those hospitalized comorbidities, such as hypertension, diabetes, or coronary artery diseases. Because viral diseases may have atypical presentations immunosuppressed course disease transplant patient population unknown. Hence, management these patients COVID-19 an area interest, and unique approach...

10.1111/tid.13296 article EN Transplant Infectious Disease 2020-04-17

Abstract Introduction Management of COVID‐19 in kidney transplant recipients should include treatment the infection, regulation immunosuppression, and supportive therapy. However, there is no consensus on this issue yet. This study aimed to our experiences with diagnosed COVID‐19. Material Methods Kidney from five major centers Istanbul, Turkey, were included retrospective cohort study. Patients classified as having moderate or severe pneumonia for analysis. The primary endpoint was...

10.1111/tid.13371 article EN Transplant Infectious Disease 2020-07-13

Abstract Background Kidney transplant recipients have an increased risk of complications from COVID-19. However, data on the allograft damage or death in kidney recovering COVID-19 is limited. In addition, first and second waves pandemic occurred at different times all over world. Turkey, Health Minister confirmed case March 2020; after that, wave between August afterward, began September 2020. This study aims to demonstrate clinical presentations two Turkey explore impact outcomes initial...

10.1186/s12882-022-02784-w article EN cc-by BMC Nephrology 2022-05-12

Coronavirus Disease-19 (COVID-19) has high mortality in kidney transplant recipients (KTR), and vaccination against severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) is vital for this population. Although the humoral response to messenger RNA vaccines was shown be impaired KTR, there a lack of data regarding antibody inactivated vaccines. We investigated two consequent doses SARS-CoV-2 vaccine (CoronaVac; Sinovac Biotech, China).

10.1111/tid.13740 article EN Transplant Infectious Disease 2021-10-05

Abstract: Endothelial dysfunction is of vital importance, as it may cause ischemia and in various organs. Despite, this problem has been well documented patients with end‐stage renal disease (ESRD), there not enough data considering issue following transplantation. One the potential causes endothelial transplant recipients be administration calcineurin inhibitors. The aim study to evaluate effects two different inhibitors [cyclosporin A (CsA) tacrolimus (FK506)] on function patients....

10.1034/j.1399-0012.2003.00030.x article EN Clinical Transplantation 2003-05-23

In Brief Background Mammalian target of rapamycin inhibitors may confer cardioprotective advantages, but clinical data are limited. Methods the open-label ELEVATE trial, kidney transplant patients were randomized at 10 to 14 weeks after convert from calcineurin inhibitor (CNI) everolimus or remain on standard CNI therapy. Prespecified end points included left ventricular mass index and, in a subpopulation patients, arterial stiffness as measured by pulse wave velocity. Results The mean...

10.1097/tp.0000000000001739 article EN Transplantation 2017-03-24

Proteinuria, developing after renal transplantation may influence allograft and patient outcomes. This study aimed to investigate the effect of proteinuria on survival. Among 514 patients, 56 (11%) patients with good function were evaluated retrospectively. Patients classified as group P (20 permanent proteinuria, Male/Female: 16/4) T (36 temporary M/F: 29/7) according type proteinuria. Also, considering amount M (32 massive 29/3) NM (24 non‐massive 16/8). The mean time interval between...

10.1034/j.1399-0012.1999.130304.x article EN Clinical Transplantation 1999-03-01

Autonomic dysfunction in hemodialysis patients is one of the components uremic neuropathy. In this prospective study, we investigated effect renal transplantation on autonomic with long-term time-domain and frequency-domain heart rate variability. Fourteen (10 male, 4 female; mean age 33 ± 11 (range 16–50) years) were examined before at early after period (mean 4.6 1.5 3–7.5) months). The time spent was 16.7 15.6 6–65) months. analysis, significant increases all parameters except pNN50 (SD,...

10.1159/000045126 article EN ˜The œNephron journals/Nephron journals 1998-01-01
Coming Soon ...